Status:

UNKNOWN

The Altered Immune Response to Exercise in Patients With Fibromyalgia Before and After a Mind-body Intervention

Lead Sponsor:

University of Kansas Medical Center

Conditions:

Fibromyalgia

Eligibility:

FEMALE

18-70 years

Phase:

NA

Brief Summary

The purpose of this study is to compare two different exercise programs to see if there are differences after exercise in fibromyalgia (FM) symptoms and responses from the immune system.

Eligibility Criteria

Inclusion

  • Inclusion Criteria for FM Patients:
  • Patients with a diagnosis of FM
  • Clearance from patient's physician to participate in a clinical trial
  • Not participating or willing to discontinue FM treatment with trans-cutaneous electrical nerve stimulation, biofeedback, tender-point injections, acupuncture, Yoga, and Tai Chi.
  • Exclusion Criteria for all Participants:
  • Diagnosis of severe psychiatric illness
  • Abuse of alcohol, benzodiazepines, or other drugs
  • Active cardiovascular, pulmonary, hepatic, renal, gastrointestinal, or autoimmune disease (except Hashimoto's or Graves' disease that has been stable for 3 months before screening)
  • Current systemic infection
  • Active cancer (except basal cell carcinoma);
  • Unstable endocrine disease
  • Severe sleep apnea
  • Prostate enlargement or other genitourinary disorder (male patients)
  • Pregnancy or breastfeeding
  • Inclusion Criteria for Healthy Controls:
  • Female
  • No apparent medical condition that will interfere with participation in the study
  • Not on any medication that will interfere with participation in this study
  • Exclusion Criteria for Healthy Controls:
  • Medical or surgical conditions including medication that preclude participation in the study
  • Presence of motor or neuromuscular deficits that may preclude participating in fatigue exercise

Exclusion

    Key Trial Info

    Start Date :

    February 1 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 20 2019

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT03441997

    Start Date

    February 1 2018

    End Date

    December 20 2019

    Last Update

    January 4 2019

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Kansas Medical Center

    Kansas City, Kansas, United States, 66160